Last $70.16 USD
Change Today -0.32 / -0.45%
Volume 791.4K
EW On Other Exchanges
Symbol
Exchange
New York
Berlin
As of 8:04 PM 06/18/13 All times are local (Market data is delayed by at least 15 minutes).

edwards lifesciences corp (EW) Snapshot

Open
$70.47
Previous Close
$70.48
Day High
$70.61
Day Low
$69.69
52 Week High
10/4/12 - $110.79
52 Week Low
05/1/13 - $62.34
Market Cap
7.9B
Average Volume 10 Days
1.3M
EPS TTM
$2.92
Shares Outstanding
113.0M
EX-Date
--
P/E TM
24.0x
Dividend
--
Dividend Yield
--
Current Stock Chart for EDWARDS LIFESCIENCES CORP (EW)

Related News

No related news articles were found.

edwards lifesciences corp (EW) Related Businessweek News

No Related Businessweek News Found

edwards lifesciences corp (EW) Details

Edwards Lifesciences Corporation provides products and technologies to treat structural heart disease and critically ill patients worldwide. The company offers surgical heart valve therapy products, such as tissue heart valves and repair products, which are used to replace or repair a patient’s diseased or defective heart valve; and produces pericardial and porcine valves. Its surgical heart valve therapy products include Carpentier-Edwards PERIMOUNT pericardial valve that comprise PERIMOUNT Magna Ease valves for aortic and mitral replacement; ThruPort systems that enable minimal incision valve surgery; and protection cannulae used during cardiac surgery in venous drainage, aortic perfusion, venting, and cardioplegia delivery. The company also provides transcatheter heart valves portfolio that includes technologies designed to treat heart valve disease using catheter-based approaches, as well as critical care products, such as hemodynamic monitoring systems to measure a patient’s heart function in surgical and intensive care settings; Swan-Ganz line of pulmonary artery catheters and PreSep continuous venous oximetry catheters for measuring central venous oxygen saturation; VolumeView sensor-catheters; FloTrac continuous cardiac output monitoring system, a minimally invasive cardiac monitoring technology for goal-directed fluid optimization; and EV1000 clinical monitoring platform, which displays a patient's physiologic status. Its critical care products also include disposable pressure monitoring devices and closed blood sampling systems to help protect both patients and clinicians from the risk of infection; and products used to treat endolumenal occlusive disease, including balloon-tipped, catheter-based embolectomy products, surgical clips, and clamps. The company distributes its products through direct sales force and independent distributors. Edwards Lifesciences Corporation was founded in 1999 and is headquartered in Irvine, California.

8,200 Employees
Last Reported Date: 02/28/13
Founded in 1999

edwards lifesciences corp (EW) Top Compensated Officers

Chairman and Chief Executive Officer
Total Annual Compensation: $825.0K
Chief Financial Officer, Principal Accounting...
Total Annual Compensation: $479.3K
Corporate Vice President of Europe, Middle Ea...
Total Annual Compensation: $582.4K
Corporate Vice President of Critical Care & V...
Total Annual Compensation: $454.1K
Corporate Vice President of Heart Valve Thera...
Total Annual Compensation: $407.8K
Compensation as of Fiscal Year 2012.

edwards lifesciences corp (EW) Key Developments

Edwards Lifesciences Corp. Announces Executive Appointments; Approves the Amendment to it's Restated Certificate of Incorporation

Edwards Lifesciences Corp. approved the elections of Bob Ingram, Bill Link and Wes von Schack as directors of the company for a three year term. The company approved the amendment to the company's restated Certificate of Incorporation to declassify the board and also approved the amendment of the company's restated Certificate of Incorporation to eliminate the supermajority voting provision.

Thomas M. Abate Plans to Retire as Chief Financial Officer of Edwards Lifesciences Corp

Edwards Lifesciences Corp. announced that Thomas M. Abate, the company's chief financial officer, plans to retire later in 2013. Abate, who turns 60 in August, plans to remain CFO until his successor is in place.

Edwards Lifesciences Corp. Presents at Goldman Sachs 34th Annual Global Healthcare Conference, Jun-11-2013 08:00 AM

Edwards Lifesciences Corp. Presents at Goldman Sachs 34th Annual Global Healthcare Conference, Jun-11-2013 08:00 AM. Venue: Terranea Resort, Rancho Palos Verdes, California, United States. Speakers: Thomas M. Abate, Chief Financial Officer, Principal Accounting Officer and Corporate Vice President.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
EW:US $70.16 USD -0.32

EW Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Hologic Inc $21.04 USD -0.39
MEDNAX Inc $92.27 USD -0.21
Mettler-Toledo International Inc $216.72 USD +0.91
ResMed Inc $47.66 USD -0.20
Cooper Cos Inc/The $121.69 USD -1.11
View Industry Companies
 

Industry Analysis

EW

Industry Average

Valuation EW Industry Range
Price/Earnings 22.3x
Price/Sales 4.1x
Price/Book 5.0x
Price/Cash Flow 21.3x
TEV/Sales 3.7x
 | 

Post a JobJobs

View all jobs

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact EDWARDS LIFESCIENCES CORP, please visit www.edwards.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.